TREVISAN, G.; GERMI, L.; NALDI, L. Erythrodermic psoriasis improved by tildrakizumab. Dermatology Reports, [S. l.], v. 14, n. 4, 2022. DOI: 10.4081/dr.2022.9448. Disponível em: https://www.pagepress.org/journals/dr/article/view/9448. Acesso em: 18 may. 2024.